Cerenome, Inc. (CNSY) stock
CNSYNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 8/3071% below fair value
$0.63−0.08 (-11.82%)
Close on Nov 17, 2026Market cap $4.78MP/E –Yield –
Cerenome enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Cerenome's enterprise value was -$2.73M on Nov 11, 2026, against $63.68M a year earlier. Over the last 5 years it ranged from -$14.18M to $983.31M, with a median of $1.03M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$2.73M | -105.4% |
| 2025 | Dec 31, 2025 | $50.82M | +2450.2% |
| 2024 | Dec 31, 2024 | $1.99M | +58.5% |
| 2023 | Dec 29, 2023 | $1.26M | – |
| 2022 | Dec 30, 2022 | -$13.86M | – |
| 2021 | Dec 31, 2021 | -$13.45M | – |
| 2020 | Dec 31, 2020 | -$826.68K | – |
| 2019 | Dec 31, 2019 | -$5.44M | -173.3% |
| 2018 | Dec 31, 2018 | $7.43M | -21.1% |
| 2017 | Dec 29, 2017 | $9.41M | +107.7% |
| 2016 | Dec 30, 2016 | $4.53M | – |
See a number that looks wrong?